Cargando…

Comparison of Staging Systems of Hepatocellular Carcinoma

Many staging systems of hepatocellular carcinoma (HCC) were established; however, there is no consensus on which is proper in predicting prognosis. This study aims to evaluate various commonly used staging systems of HCC. Patients who underwent surgery during 2001–2007 were included. All patient dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirivatanauksorn, Yongyut, Tovikkai, Chutwichai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132503/
https://www.ncbi.nlm.nih.gov/pubmed/21760664
http://dx.doi.org/10.1155/2011/818217
_version_ 1782207834238222336
author Sirivatanauksorn, Yongyut
Tovikkai, Chutwichai
author_facet Sirivatanauksorn, Yongyut
Tovikkai, Chutwichai
author_sort Sirivatanauksorn, Yongyut
collection PubMed
description Many staging systems of hepatocellular carcinoma (HCC) were established; however, there is no consensus on which is proper in predicting prognosis. This study aims to evaluate various commonly used staging systems of HCC. Patients who underwent surgery during 2001–2007 were included. All patient data were retrospectively staged using six staging systems, that are American Joint Committee on Cancer (AJCC) Tumour-Node-Metastasis (TNM), Okuda staging, Cancer of the Liver Italian Program (CLIP), Barcelona Clinic Liver Cancer (BCLC), Chinese University Prognostic Index (CUPI), and Japan Integrated Staging (JIS). Child-Pugh classification was also evaluated. The staging systems were compared by mean of overall and disease-free survival. Total of 99 patient data were enrolled in the analyses. All staging systems except Okuda were significant in determining overall survival in univariate analyses. In multivariate analyses, TNM and Child-Pugh demonstrated better predictive power for overall survival. In terms of disease-free survival, univariate analyses revealed that TNM, CLIP, BCLC, CUPI, and JIS were significant, and TNM was the best predictive staging system in multivariate analyses. In our study, TNM and Child-Pugh are the representative systems in predicting survival of HCC patients who undergo surgical resection. Moreover, they are practical and easily assessable in clinical practice.
format Online
Article
Text
id pubmed-3132503
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31325032011-07-14 Comparison of Staging Systems of Hepatocellular Carcinoma Sirivatanauksorn, Yongyut Tovikkai, Chutwichai HPB Surg Clinical Study Many staging systems of hepatocellular carcinoma (HCC) were established; however, there is no consensus on which is proper in predicting prognosis. This study aims to evaluate various commonly used staging systems of HCC. Patients who underwent surgery during 2001–2007 were included. All patient data were retrospectively staged using six staging systems, that are American Joint Committee on Cancer (AJCC) Tumour-Node-Metastasis (TNM), Okuda staging, Cancer of the Liver Italian Program (CLIP), Barcelona Clinic Liver Cancer (BCLC), Chinese University Prognostic Index (CUPI), and Japan Integrated Staging (JIS). Child-Pugh classification was also evaluated. The staging systems were compared by mean of overall and disease-free survival. Total of 99 patient data were enrolled in the analyses. All staging systems except Okuda were significant in determining overall survival in univariate analyses. In multivariate analyses, TNM and Child-Pugh demonstrated better predictive power for overall survival. In terms of disease-free survival, univariate analyses revealed that TNM, CLIP, BCLC, CUPI, and JIS were significant, and TNM was the best predictive staging system in multivariate analyses. In our study, TNM and Child-Pugh are the representative systems in predicting survival of HCC patients who undergo surgical resection. Moreover, they are practical and easily assessable in clinical practice. Hindawi Publishing Corporation 2011 2011-06-27 /pmc/articles/PMC3132503/ /pubmed/21760664 http://dx.doi.org/10.1155/2011/818217 Text en Copyright © 2011 Y. Sirivatanauksorn and C. Tovikkai. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Sirivatanauksorn, Yongyut
Tovikkai, Chutwichai
Comparison of Staging Systems of Hepatocellular Carcinoma
title Comparison of Staging Systems of Hepatocellular Carcinoma
title_full Comparison of Staging Systems of Hepatocellular Carcinoma
title_fullStr Comparison of Staging Systems of Hepatocellular Carcinoma
title_full_unstemmed Comparison of Staging Systems of Hepatocellular Carcinoma
title_short Comparison of Staging Systems of Hepatocellular Carcinoma
title_sort comparison of staging systems of hepatocellular carcinoma
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132503/
https://www.ncbi.nlm.nih.gov/pubmed/21760664
http://dx.doi.org/10.1155/2011/818217
work_keys_str_mv AT sirivatanauksornyongyut comparisonofstagingsystemsofhepatocellularcarcinoma
AT tovikkaichutwichai comparisonofstagingsystemsofhepatocellularcarcinoma